Product Composition
Each tablet of Alerzip-3D contains the following active ingredients:
-
Levocetirizine Hydrochloride (5 mg): An antihistamine that reduces allergy symptoms like runny nose and watery eyes.
-
Montelukast Sodium (10 mg): A leukotriene receptor antagonist used to manage asthma and allergic rhinitis.
-
Ambroxol Hydrochloride (SR) (75 mg): A mucolytic agent in a sustained-release (SR) form that thins and loosens mucus in the airways.
-
Color: Titanium Dioxide IP.
Product Summary
Alerzip-3D is a triple-action combination therapy marketed by Healthgate. It is specifically designed to address complex respiratory issues where allergy, airway inflammation, and mucus congestion occur simultaneously. By combining an antihistamine, an anti-inflammatory agent, and a mucus thinner, it provides comprehensive relief for conditions like allergic bronchitis, asthma associated with rhinitis, and chronic productive cough.
Pros and Cons
Pros
-
Comprehensive Relief: Targets three different symptoms (allergy, inflammation, and mucus) in a single dose.
-
Sustained Release: The Ambroxol component is formulated as “SR” to provide long-lasting relief from congestion.
-
Effective for Night Symptoms: Especially helpful for patients whose cough or asthma worsens at night due to allergies.
Cons
-
Drowsiness: Levocetirizine can cause mild sleepiness in some individuals.
-
Side Effects: May cause dry mouth, headache, or mild gastrointestinal discomfort.
-
Specific Monitoring: Montelukast requires monitoring for mood-related changes in some patients.
How to Use
-
Dosage: As directed by the physician.
-
Administration: Swallow the tablet whole with water. Do not crush or chew, as this may interfere with the sustained-release (SR) properties of the Ambroxol.
-
Timing: Often taken once daily, preferably in the evening, to manage overnight respiratory symptoms.
-
Storage: Store in a cool, dry, and dark place, protected from direct sunlight.
Warning: This is a Schedule H Prescription Drug and must be used only under medical supervision.
